DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 892 filers reported holding DANAHER CORPORATION in Q1 2014. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $7,422,000 | +324.8% | 79,960 | +292.5% | 0.12% | +254.5% |
Q3 2017 | $1,747,000 | +85.1% | 20,370 | +82.0% | 0.03% | +73.7% |
Q2 2017 | $944,000 | +12.0% | 11,193 | +13.5% | 0.02% | +11.8% |
Q1 2017 | $843,000 | +8.1% | 9,858 | -1.6% | 0.02% | +6.2% |
Q4 2016 | $780,000 | +6.0% | 10,023 | +6.7% | 0.02% | +6.7% |
Q3 2016 | $736,000 | -22.4% | 9,393 | 0.0% | 0.02% | -21.1% |
Q2 2016 | $949,000 | +6.4% | 9,393 | 0.0% | 0.02% | +11.8% |
Q1 2016 | $892,000 | +2.3% | 9,393 | 0.0% | 0.02% | 0.0% |
Q4 2015 | $872,000 | +8.9% | 9,393 | 0.0% | 0.02% | +6.2% |
Q3 2015 | $801,000 | -0.4% | 9,393 | 0.0% | 0.02% | -5.9% |
Q2 2015 | $804,000 | +18.4% | 9,393 | +17.4% | 0.02% | +13.3% |
Q1 2015 | $679,000 | -4.5% | 7,998 | -3.6% | 0.02% | -6.2% |
Q4 2014 | $711,000 | +16.9% | 8,298 | +3.8% | 0.02% | +14.3% |
Q3 2014 | $608,000 | +22.3% | 7,998 | +26.8% | 0.01% | +27.3% |
Q2 2014 | $497,000 | +5.1% | 6,309 | 0.0% | 0.01% | +10.0% |
Q1 2014 | $473,000 | +12.9% | 6,309 | +16.1% | 0.01% | +11.1% |
Q4 2013 | $419,000 | +11.1% | 5,432 | 0.0% | 0.01% | 0.0% |
Q3 2013 | $377,000 | +9.6% | 5,432 | 0.0% | 0.01% | +12.5% |
Q2 2013 | $344,000 | – | 5,432 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
Third Point | 2,490,000 | $730,392,000 | 9.51% |
Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |